INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: Wednesday, October 3, 2007

Time:  9:30 am – 5:00 pm (Estimated)

Location:

EXECUTIVE PRESENTATIONS

5. Chairman’s Report.
6. President’s Report.
     a. CIRM Scholar Meeting Report
     b. Grant Administration Update
     c. CIRM Current and Future Initiatives

ACTION ITEMS

   7. Consideration of Amendments to Grants Administration Policy regarding Facilities:
         a. Consideration of recommendations from Facilities Working Group regarding Chapter 8 of Grants
              Administration Policy for RFA 07-03.             

• AMENDMENTS/UPDATES to GAP for Major Facilities Grants As Approved by the Facilities Working Group on 10/2/07 for Recommendation to the ICOC

  b.Consideration of recommendations from CIRM President regarding Facilities Direct, covered in Chapter 5
      of the Grants Administration Policy.

   8. Consideration of Concept for Disease Team Planning Awards.
          h. Item 8 Slides

   9.  Consideration of Concept for New Cell Lines Awards.

           a. Item 9 Slides

   10. Consideration of Grants Management System software and services provider.

            a. Item 10 Slides

    11. Consideration of creation of:
            a. Finance Subcommittee of the ICOC
            b. Biotech Loan Program ICOC Task Force

CLOSED SESSION

  12.  
            a. Pending Litigation (Government Code section 11126, subdivision (e)): Mary Scott Doe v. Robert Klein, et
                 al., U.S. Court of Appeals for the Ninth Circuit, Case No. 06-55387.
            b. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section
                125290.30(d) (3) (D)).

OPEN SESSION

  13. Public report of any action taken, if necessary, during closed session.

DISCUSSION ITEMS
 

14. Summary of the 2006-07 Administrative Budget and Contract close-out. * UPDATED DOCUMENT POSTED *
15. Update on CSU discussions.
16. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.